ETFMG 2X Daily Alternative Harvest ETF (MJXL)
- Previous Close
0.3900 - Open
0.4000 - Bid --
- Ask --
- Day's Range
0.3610 - 0.3917 - 52 Week Range
0.3603 - 0.9250 - Volume
13,580 - Avg. Volume
0 - Net Assets 657.3k
- NAV 0.39
- PE Ratio (TTM) --
- Yield 0.00%
- YTD Daily Total Return -87.32%
- Beta (5Y Monthly) 0.00
- Expense Ratio (net) 1.01%
The financial instruments in which the fund most commonly invests are swap agreements which are intended to produce economically leveraged investment results. The index tracks the performance of the common stock of companies across the globe. The fund is non-diversified.
ETFMG
Fund Family
Trading--Leveraged Equity
Fund Category
657.3k
Net Assets
2021-07-06
Inception Date
Performance Overview: MJXL
Trailing returns as of 12/31/2022. Category is Trading--Leveraged Equity.
Holdings: MJXL
Top 1 Holdings (347.15% of Total Assets)
Related ETF News
Research Reports: MJXL
Canada Cannabis Market Remains a Challenge, but Tilray Continues EBITDA Profitability Streak in Q2
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
RatingPrice TargetTilray’s First Full Quarter Post Merger Understates Full Margin Potential; Shares Undervalued
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
RatingPrice TargetOur Doubt of Positive EBITDA in Canopy’s FY2022 Proves Correct, but Wider Q2 Losses Lower Our FVE
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
RatingPrice TargetGreen Thumb Maintains Solid Profitability Despite Top-Line Headwinds in Q3; Shares Very Undervalued
Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates more than 60 cannabis stores under the chains Rise and Essence. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to U.S. federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including Dr. Solomon’s, Dogwalkers, and Beboe.
RatingPrice Target